image
Biodexa Pharmaceuticals Plc BDRX
Healthcare - Biotechnology - NASDAQ - GB
Watchlist
$ 3.62
-25.9 %
$ 2.1 M
Market Cap
-0.05
P/E
INCOME STATEMENT
381 K REVENUE
-45.49%
Growth Rates
1Year -45.49%
3Years 3.56%
5Years -27.77%
7Years -16.29%
10Years 9.99%
-8.01 M OPERATING INCOME
10.28%
Growth Rates
1Year 10.28%
3Years 9.10%
5Years 7.47%
7Years 2.62%
10Years -5.94%
-7.08 M NET INCOME
7.54%
Growth Rates
1Year 7.54%
3Years 31.67%
5Years 13.98%
7Years 13.89%
10Years -5.65%
EFFICIENCY
Earnings Waterfall Biodexa Pharmaceuticals Plc
image
Revenue 381 K
Cost Of Revenue 4.07 M
Gross Profit -3.69 M
Operating Expenses 4.33 M
Operating Income -8.01 M
Other Expenses -935 K
Net Income -7.08 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 0.4 0.7 0.6 0.3 0.7 1.9 1.0 1.3 1.4 0.2 0.1 0
GROSS PROFIT
Cost Of Revenue 4.1 5.1 4.7 6.1 7.8 9.4 8.3 7.7 70 K 0 0 0
Gross Profit (3.7) (4.4) (4.1) (5.7) (7.2) (7.4) (7.3) (6.4) 1.3 0.2 0.1 0
OPERATING INCOME
Operating Expenses 4.3 4.1 2.0 17.7 3.7 4.4 5.5 2.1 12.6 9.8 4.6 4.0
Selling, General and Administrative Expenses 4.3 4.5 2.9 5.0 4.2 4.4 4.4 3.2 2.7 4.2 1.8 2.4
Research and Development Expenses 4.1 5.1 4.7 16.1 7.8 9.4 9.8 7.7 8.7 5.4 2.8 1.7
Operating Income (8.0) (8.9) (7.0) (10.7) (11.3) (11.8) (11.8) (9.7) (10.1) (7.7) (4.5) (4.0)
PRE-TAX INCOME
Interest Income Expense 41 K 53 K 44 K 34 K 97 K 0.6 0.1 0 0 0.2 0.2 0
Total Other Income 0.5 0.4 0.9 (0.4) 0.4 (0.6) (1.2) 1.3 1.7 (0.2) (0.4) (0.6)
Pre-Tax Income (7.5) (8.5) (6.1) (23.5) (10.9) (12.4) (13.0) (8.4) (11.2) (9.8) (4.9) (4.6)
NET INCOME
Tax Provision (0.4) 0.8 0.6 1.3 1.8 2.0 1.3 2.2 1.1 1.0 0.8 0.6
Net Income (7.1) (7.7) (5.5) (22.2) (9.1) (10.4) (11.7) (6.2) (10.1) (8.8) (4.1) (4.0)
EPS 224 620 542 4.14 K 3.99 K 0 0 0 0 0 0 0